Etoacetazene
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Etoacetazene (Etonitazene 5-acetyl analogue, 5-acetyldesnitroetonitazene) is a benzimidazole derivative with opioid effects, first developed in the 1950s as part of the research that led to better-known compounds such as etonitazene. It is an analogue of etonitazene where the 5-nitro (NO 2 ) group has been replaced by an acetyl (COCH 3 ) group. It is described as having "reduced but still significant" potency compared to etonitazene itself. This compound was also tested as part of a series of cannabinoid receptor 2 agonists, and was found to be active though with fairly low potency of 960 nM at CB 2 , and negligible activity at CB 1 .
Etoacetazene (Etonitazene 5-acetyl analogue, 5-acetyldesnitroetonitazene) is a benzimidazole derivative with opioid effects, first developed in the 1950s as part of the research that led to better-known compounds such as etonitazene. It is an analogue of etonitazene where the 5-nitro (NO 2 ) group has been replaced by an acetyl (COCH 3 ) group. It is described as having "reduced but still significant" potency compared to etonitazene itself. This compound was also tested as part of a series of cannabinoid receptor 2 agonists, and was found to be active though with fairly low potency of 960 nM at CB 2 , and negligible activity at CB 1 .
Text derived from https://en.wikipedia.org/w/index.php?oldid=1306180927 under CC BY-SA 4.0; modifications have been made.